Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Moodys
US Army
Baxter
Covington
Cerilliant
Boehringer Ingelheim
Fuji

Generated: May 26, 2018

DrugPatentWatch Database Preview

Schwarz Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for SCHWARZ PHARMA, and what generic and branded alternatives to SCHWARZ PHARMA drugs are available?

SCHWARZ PHARMA has four approved drugs.



Summary for Schwarz Pharma
US Patents:0
Tradenames:5
Ingredients:4
NDAs:4
Patent Litigation for Schwarz Pharma: See patent lawsuits for Schwarz Pharma

Drugs and US Patents for Schwarz Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schwarz Pharma AZDONE aspirin; hydrocodone bitartrate TABLET;ORAL 089420-001 Jan 25, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Schwarz Pharma PREDNICEN-M prednisone TABLET;ORAL 084655-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Schwarz Pharma CODIMAL-L.A. 12 chlorpheniramine maleate; pseudoephedrine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018935-001 Apr 15, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Schwarz Pharma THEOCLEAR L.A.-260 theophylline CAPSULE, EXTENDED RELEASE;ORAL 086569-002 May 27, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Fish and Richardson
Medtronic
Colorcon
UBS
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.